Logo

Purely Proteins Raises First-Round Venture Financing

Nov 26, 2003

NEW YORK, Nov. 26 (GenomeWeb News) - Purely Proteins of Cambridge, UK said late yesterday it had raised an initial round of venture financing, but did not disclose the amount of the financing.

 

The company's business involves purification of suites of human proteins, as well as drug discovery services for therapeutic targets of these proteins that brings together in silico and biochemical approaches, according to David Parry-Smith, COO.

 

The funding round was led by Avlar BioVentrues and Yorkshire Fund Managers.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.